Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity
Clinical trial NCT03552757 · COMPLETED
Trial details
- NCT number
- NCT03552757
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-04
- Primary completion
- 2020-03-24
- Enrollment
- 1210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.